Published in J Neuroinflammation on November 18, 2010
Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci Transl Med (2012) 3.53
Progress in gene therapy for neurological disorders. Nat Rev Neurol (2013) 1.22
Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN Deficiency. Mol Ther (2016) 1.06
Finding a better drug for epilepsy: antiepileptogenesis targets. Epilepsia (2012) 0.99
The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics (2014) 0.93
Status epilepticus triggers early and late alterations in brain-derived neurotrophic factor and NMDA glutamate receptor Grin2b DNA methylation levels in the hippocampus. Neuroscience (2013) 0.92
Environmental enrichment attenuates hippocampal neuroinflammation and improves cognitive function during influenza infection. Brain Behav Immun (2012) 0.89
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. Front Cell Neurosci (2013) 0.87
Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain. J Neuroinflammation (2013) 0.85
Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy. PLoS One (2011) 0.85
Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia. Cytokine (2012) 0.84
FGF-2 released from degenerating neurons exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway. J Neuroinflammation (2014) 0.82
IL-1RAcPb signaling regulates adaptive mechanisms in neurons that promote their long-term survival following excitotoxic insults. Front Cell Neurosci (2013) 0.82
Current prospects and challenges for epilepsy gene therapy. Exp Neurol (2011) 0.80
Excitotoxic brain injury in adult zebrafish stimulates neurogenesis and long-distance neuronal integration. Glia (2014) 0.79
A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts. Mol Neurobiol (2014) 0.78
Gene therapy in epilepsy-is it time for clinical trials? Nat Rev Neurol (2014) 0.77
Regenerative medicine for epilepsy: from basic research to clinical application. Int J Mol Sci (2013) 0.76
Silencing Status Epilepticus-Induced BDNF Expression with Herpes Simplex Virus Type-1 Based Amplicon Vectors. PLoS One (2016) 0.75
Peroxisome proliferator-activated receptor-γ agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus. Mol Med Rep (2015) 0.75
Neurobehavioral effects of vigabatrin and its ability to induce DNA damage in brain cells after acute treatment in rats. Psychopharmacology (Berl) (2016) 0.75
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med (2010) 4.61
Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia (2005) 3.87
Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain (2006) 3.86
Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci (2004) 3.17
A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med (2008) 3.16
Seizure-promoting effect of blood-brain barrier disruption. Epilepsia (2007) 3.00
TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain (2006) 2.80
Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia (2001) 2.63
Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol (2002) 2.43
The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci (2000) 2.18
Chemokines: a new class of neuromodulator? Nat Rev Neurosci (2007) 1.76
Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis (2008) 1.74
Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia (2002) 1.66
Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus. J Neurosci (2007) 1.64
Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc Med (2007) 1.56
Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog Brain Res (2007) 1.54
Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol (2007) 1.46
Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants. J Neurosci (2003) 1.33
Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res (2009) 1.29
Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J Leukoc Biol (2008) 1.25
The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J Neurosci (2002) 1.24
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc Natl Acad Sci U S A (2009) 1.18
The emerging role for chemokines in epilepsy. J Neuroimmunol (2010) 1.12
Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis. Neurobiol Dis (2009) 1.07
Vascular changes in epilepsy: functional consequences and association with network plasticity in pilocarpine-induced experimental epilepsy. Neuroscience (2009) 1.01
Angels and demons: neurotrophic factors and epilepsy. Trends Pharmacol Sci (2006) 0.97
Tooth pulp inflammation increases brain-derived neurotrophic factor expression in rodent trigeminal ganglion neurons. Neuroscience (2010) 0.97
Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury. J Neuroinflammation (2006) 0.95
Characterization of reactive astrocytes in the chronic phase of the pilocarpine model of epilepsy. Epilepsia (2002) 0.91
ProBDNF inhibits infiltration of ED1+ macrophages after spinal cord injury. Brain Behav Immun (2010) 0.90
Neurotrophins and their receptors in human lingual tonsil: an immunohistochemical analysis. Oncol Rep (2008) 0.88
Enhancement of GABA(A)-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy. Proc Natl Acad Sci U S A (2010) 0.85
Pilocarpine-induced seizures revisited: what does the model mimic? Epilepsy Curr (2009) 0.83
Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches. Ann N Y Acad Sci (2007) 0.83
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo. Gene Ther (1999) 0.81
A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med (2008) 3.16
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis. J Neurosci (2004) 1.51
p21(Waf1/Cip1/Sdi1) mediates shear stress-dependent antiapoptotic function. Cardiovasc Res (2004) 1.48
Identification of new epilepsy treatments: issues in preclinical methodology. Epilepsia (2012) 1.45
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity (2008) 1.34
A revised Racine's scale for PTZ-induced seizures in rats. Physiol Behav (2009) 1.32
Obesity and inflammation: evidence for an elementary lesion. Pediatrics (2006) 1.30
Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma. Clin Cancer Res (2005) 1.27
In vivo assessment of antiangiogenic activity of SU6668 in an experimental colon carcinoma model. Clin Cancer Res (2004) 1.18
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc Natl Acad Sci U S A (2009) 1.18
Modeling and remodeling of human extraction sockets. J Clin Periodontol (2008) 1.13
Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism. Neoplasia (2007) 1.12
High field MRI in preclinical research. Eur J Radiol (2003) 1.12
alpha-Gustducin immunoreactivity in the airways. Cell Tissue Res (2004) 1.11
Acyl homoserine lactones induce early response in the airway. Anat Rec (Hoboken) (2009) 1.10
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies. J Pharmacol Exp Ther (2007) 1.09
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. J Neurosci (2005) 1.06
In vivo phenotyping of the ob/ob mouse by magnetic resonance imaging and 1H-magnetic resonance spectroscopy. Obesity (Silver Spring) (2006) 1.05
In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S. J Pharmacol Exp Ther (2008) 1.05
Laryngeal chemosensory clusters. Chem Senses (2004) 1.01
Identification and characterization of a specific sensory epithelium in the rat larynx. J Comp Neurol (2004) 1.00
Finding a better drug for epilepsy: antiepileptogenesis targets. Epilepsia (2012) 0.99
HSV Recombinant Vectors for Gene Therapy. Open Virol J (2010) 0.99
Evidence of solitary chemosensory cells in a large mammal: the diffuse chemosensory system in Bos taurus airways. J Anat (2006) 0.99
Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids? Cardiovasc Res (2012) 0.99
Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain. J Pharmacol Exp Ther (2003) 0.98
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus. Epilepsia (2011) 0.97
Evaluation of cell damage in organotypic hippocampal slice culture from adult mouse: a potential model system to study neuroprotection. Brain Res (2011) 0.97
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression. Neurobiol Dis (2006) 0.95
Idiopathic eruptive macular pigmentation in a 50-year-old man. Eur J Dermatol (2010) 0.94
Glucose transporters are expressed in taste receptor cells. J Anat (2011) 0.94
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis. Psychopharmacology (Berl) (2007) 0.94
Pilocarpine-induced status epilepticus in rats involves ischemic and excitotoxic mechanisms. PLoS One (2007) 0.93
Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures. Epilepsia (2011) 0.93
Classic hippocampal sclerosis and hippocampal-onset epilepsy produced by a single "cryptic" episode of focal hippocampal excitation in awake rats. J Comp Neurol (2010) 0.93
Does pilocarpine-induced epilepsy in adult rats require status epilepticus? PLoS One (2009) 0.92
Mesenchymal/stromal gene expression signature relates to basal-like breast cancers, identifies bone metastasis and predicts resistance to therapies. PLoS One (2010) 0.92
Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors. Proc Natl Acad Sci U S A (2008) 0.92
Fgf-2 overexpression increases excitability and seizure susceptibility but decreases seizure-induced cell loss. J Neurosci (2008) 0.91
Finding a better drug for epilepsy: antiinflammatory targets. Epilepsia (2012) 0.91
In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure. Int J Cancer (2003) 0.90
What is the biological significance of BDNF mRNA targeting in the dendrites? Clues from epilepsy and cortical development. Mol Neurobiol (2006) 0.90
The stimulation of A(3) adenosine receptors reduces bone-residing breast cancer in a rat preclinical model. Eur J Cancer (2012) 0.89
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats. Brain Res (2002) 0.89
The diffuse chemosensory system: exploring the iceberg toward the definition of functional roles. Prog Neurobiol (2010) 0.89
Secretory cells of the airway express molecules of the chemoreceptive cascade. Cell Tissue Res (2006) 0.89
Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo. J Immunol (2008) 0.89
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol (2003) 0.89
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. Carcinogenesis (2005) 0.88
GABA(A)-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABA(A) "phasic" receptors. Proc Natl Acad Sci U S A (2007) 0.88
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. Front Cell Neurosci (2013) 0.87
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease. Mov Disord (2010) 0.87
Magnetic resonance imaging of the rat Harderian gland. J Anat (2002) 0.87
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice. Peptides (2007) 0.87
Protein kinase C activity, translocation, and selective isoform subcellular redistribution in the rat cerebral cortex after in vitro ischemia. J Neurosci Res (2003) 0.87
Assessment of cerebral blood volume in schizophrenia: A magnetic resonance imaging study. J Psychiatr Res (2006) 0.87
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors. J Gene Med (2010) 0.87
Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target. Eur J Nucl Med Mol Imaging (2008) 0.86
On the role of somatostatin in seizure control: clues from the hippocampus. Rev Neurosci (2003) 0.86
A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb. Pflugers Arch (2008) 0.86
Cerebral perfusion alterations in epileptic patients during peri-ictal and post-ictal phase: PASL vs DSC-MRI. Magn Reson Imaging (2013) 0.86
Contrast-enhanced MRI of brown adipose tissue after pharmacological stimulation. Magn Reson Med (2006) 0.86
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist. Neuroreport (2002) 0.86
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex. Eur J Neurosci (2004) 0.86
Primary lacrimal sac B-cell immunoblastic lymphoma simulating an acute dacryocystitis. Orbit (2003) 0.85